Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07489079 · ClinicalTrials.gov registry record · NA
PlayReadVIP in Family Child Care
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT07489079: Recruiting NA study, sponsored by NYU Langone Health.
NCT07489079 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07489079, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study uses a mixed-methods, single-group pretest-posttest design to evaluate (1) implementation outcomes (acceptability, adoption, fidelity) and (2) preliminary changes associated with delivery of the adapted PlayReadVIP intervention in Family Care Center (FCC) settings.
Primary Outcome
Provider self-efficacy is measured using the Beliefs About Parent Support for Early Literacy Scale (BPSES). The BPSES consists of items assessing providers' confidence in managing children's behavior and supporting children's development. Items are rated on a 5-point Likert scale ranging from Strongly disagree to Strongly agree. The total score is calculated by summing all five items, and ranges from 5 to 25, with higher scores indicating greater provider self-efficacy.
Interventions
- BEHAVIORAL PlayReadVIP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-05-27 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT07489079 shows while recruiting
NCT07489079 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which PlayReadVIP is the first listed.
NCT07489079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07489079 about?
NCT07489079 is a clinical study titled "PlayReadVIP in Family Child Care". This study uses a mixed-methods, single-group pretest-posttest design to evaluate (1) implementation outcomes (acceptability, adoption, fidelity) and (2) preliminary changes associated with delivery of the adapted PlayReadVIP intervention in Family Care Center (FCC) settings.
What is the current status of trial NCT07489079?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2026-05-27. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07489079?
The interventions under investigation include: PlayReadVIP (BEHAVIORAL).
Who is sponsoring clinical trial NCT07489079?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07489079's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI